AzTrials
AzTrials

HyperkyphosisNCT03212664

Physical Therapy Exercises in Hyperkyphosis

A study testing exercise in people with Hyperkyphosis, run by Texas Scottish Rite Hospital for Children at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This proposal is a single center preliminary prospective cohort trial that evaluates patients with hyperkyphosis. Participants will receive physical therapy exercises and be followed for the above outcome measures over time. The treatment arm will receive training in one-time training in kyphosis-specific exercises. Read more about this study

Who is it for?
Ages 10 to 18 years
Conditions the study is for
Hyperkyphosis
What is being tested?
exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteUnited States
Study dates
5 Aug 2014to 5 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • diagnosis of hyperkyphosis
  • ages 10 to 18 years
  • Cobb angles at least 50°
  • pain >2 on the VAS during the past week.

Who cannot join

  • scoliosis greater than 25°
  • conditions preventing understanding and compliance with an exercise schedule
  • current brace wear
  • previous spine surgery
  • inability to commit to at least 15 minutes of exercises for 3 days a week
  • pain <2 on the VAS during the past week.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas Scottish Rite Hospital for Children

    Dallas, Texas, 75219

Other trials in United States

About this study

Official title: Effectiveness of Physical Therapy Exercises in Hyperkyphosis

This proposal is a single center preliminary prospective cohort trial that evaluates patients with hyperkyphosis. Participants will receive physical therapy exercises and be followed for the above outcome measures over time. The treatment arm will receive training in one-time training in kyphosis-specific exercises.

It is hypothesized that participants receive physical therapy exercises will demonstrate improved outcome measures over time. Also, it is hypothesized that participants who receive kyphosis-specific exercises will demonstrate significantly improved perceived quality-of-life and significantly reduced pain, compared to participants who receive generalized back exercises after 6 months.

Also, it is hypothesized that a kyphosis-specific SAQ will demonstrate satisfactory test-retest reliability and concurrent validity.

Read the detailed description

A total of 50 patients will be recruited for this study. 28 patients will be recruited for both groups, or 14 participants per group. Patients will be randomized by an independent research assistant who will draw the group number from a hat. We assume less than 15% attrition, which results in 12 participants per group.

Patients in both groups will ideally be followed after 6 months, unless the patient's treating orthopaedic surgeon schedules them for a visit up until 12 months later.

Group 1(Kyphosis-specific exercise Group): Patients will receive a one-time treatment consisting of kyphosis-specific exercises that promote depressing the thoracic convexity.

Group 2 (Generalized exercise group): Patients will receive a one-time treatment consisting of core strengthening, hamstring stretching, and generalized back extension exercises.

Patients in each group will be asked to perform these exercises at home about 10 minutes a day, 3 times a week.

Each patient will be given access to a software application though PT PAL on their smart phone (or computer). Patients will be asked to use the app whenever they perform their exercises throughout the 6 month period. Patients must turn off the app after 15 minutes for the app to count the exercise session as complete. Each physical therapist participating in the study will have administrator access to monitor exercise adherence for their respective patients at any time as a tool to maximize exercise adherence.

Each patient will also be asked about their pain intensity on a monthly basis through a secure database (REDCap).

  1. Study Procedures: Group 1 or 2

Month 0 (40 minutes):

  • X-ray of back [standard of care]
  • Picture of back [research]
  • Physical therapy program [research]
  • Two surveys on how kyphosis affects the patient [research]
  • Physical examination [research]

Week 2 (10 minutes):

  • Two surveys at home on how kyphosis affects the patient [research]

Months 1-5 (2 minutes)

  • Monthly survey at home regarding your back pain [research]

Month 6-12 (40 minutes):

  • X-ray of back [standard of care]
  • Picture of back [research]
  • Two surveys on how kyphosis affects the patient [research]
  • Physical examination [research]

These x-rays will not need to be ordered as a study procedure.

5a. Sub-Study: Aim 2 Kyphosis-Specific SAQ (K-SAQ) The secondary aim of this study is to assess the psychometric properties of a kyphosis-specific SAQ and evaluate the test-retest reliability and concurrent validity of this kyphosis-specific SAQ.

The original study design included enrolling a total of 28 patients, all of whom would receive and complete the SRS-22 and the kyphosis-specific SAQ at baseline, two weeks, and 6-12 month follow-up.

At the conclusion of initial enrollment, 21 patients had been enrolled and six (6) were lost to follow-up. Of the 21 total patients, 15 completed Aim 1 of this study, not all of which completed Aim 2.

During analysis, we found statistical significance for the test-retest reliability and concurrent validity of the K-SAQ, but due to weak enrollment and completion of the questionnaires at baseline and two weeks, we are enrolling more patients for Aim 2 of the original study design and will end enrollment for Aim 2 at the conclusion of 25 completed responses of the K-SAQ and SRS-22 for both baseline and 2-week follow-up.

We will increase enrollment from 28 patients to 50 patients.

Patients in this sub-group must be diagnosed with hyperkyphosis, have a Cobb angle of at least 50°, and be 8-21 years old. Exclusion criteria includes: scoliosis greater than 25°, current brace wear, and previous spine surgery. Specific treatment is not a part of this sub-group.

Patients enrolled in the Kyphosis-specific SAQ Sub-group of the PPKS Registry (STU 032011-130) will be included within this sub-group for data analysis.

  1. Criteria for Inclusion of Subjects: Patients with a diagnosis of hyperkyphosis meeting the following inclusion criteria will be eligible to participate: ages 10 to 18 years, Cobb angles at least 50°, and pain >2 on the VAS during the past week.
  2. Criteria for Exclusion of Subjects:

Patients will be excluded according to the following exclusion criteria:

scoliosis greater than 25°, conditions preventing understanding and compliance with an exercise schedule, current brace wear, previous spine surgery, inability to commit to at least 15 minutes of exercises for 3 days a week, and pain <2 on the VAS during the past week.

  1. Sources of Research Material: Baseline participant characteristics will include age, sex, ethnicity, Risser sign, height, weight, BMI, curve magnitude of a lateral radiograph, and location of the kyphosis apex. The lateral radiograph information will be obtained from Synapse, a radiology information system at TSRH.

Exercise adherence will be recorded including the length of exercise sessions and total duration of PT until the patient is discharged to a HEP. HEP adherence will be calculated as the percentage of prescribed exercises completed from baseline to 6 months.

  1. Recruitment Methods and Consenting Process: Patients will be screened by the investigators, participating physical therapists, or research coordinator to determine whether inclusion criteria is met. If the patient is eligible for this trial, the patient will be offered enrollment to the patient and caregiver. Appropriate patient assent and caregiver consent to participate in the trial will be obtained per IRB protocol. The patient will then choose to be in either the treatment or observation group.
  2. Potential Risks: Identifiable risk associated with participation in this study would be a potential loss of confidentiality and tired or sore muscles from the exercises.
Conditions
Hyperkyphosis
Being tested
exercise
Medical subject headings
Kyphosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • exerciseOther

    physical therapy exercises

Study groups in NCT03212664
Study groupRoleWhat they receive
ExerciseOtherSchroth-based physical therapy exercises for patients who agree to participate in exercises. Will be compared to observation-only treatment
Receives: Other: exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. survey

    19 items that identify factors related to exercise adherence, app usability and acceptability

    Measured: 6 month follow-up

Secondary outcomes (2)
  1. pain intensity

    Numeric Pain Rating Scale

    Measured: baseline

  2. pain intensity

    Numeric Pain Rating Scale

    Measured: 6 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2017
  2. Study start5 Aug 2014
  3. Primary completion1 Mar 2017
  4. Study completion5 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03212664
Sponsor's protocol ID
1143
Status last verified
Sep 2021
First submitted
3 Jul 2017
Last updated
8 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zapata KA, Wang-Price SS, Fletcher TS, Johnston CE. Factors influencing adherence to an app-based exercise program in adolescents with painful hyperkyphosis. Scoliosis Spinal Disord. 2018 Jul 18;13:11. doi: 10.1186/s13013-018-0159-x. eCollection 2018.

    PubMed 30027121

Questions about this trial

What is this clinical trial studying?

A study testing exercise in people with Hyperkyphosis, run by Texas Scottish Rite Hospital for Children at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

survey (time frame: 6 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03212664, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in